Clinical Trials for Molecularly Targeted Cancer Therapeutics

Venue: Washington DC

Location: Washington DC, United States

Event Date/Time: Jan 26, 2004 End Date/Time: Jan 28, 2004
Report as Spam

Description

Keynote presentation:
Tak Mak, Ph.D.
Director
Division of Cellular and Molecular Biology
AMDI Institute, PMH

Monday January 26, 2003 Two Pre-Conference Workshops:

Strategies to Meeting Recruitment Rates and Overcoming Patient Enrollment Obstacles
Lead by Michael Schuster, MD, Director of Clinical Trials, Division of Hematology/Oncology
NEW YORK PRESBYTERIAN HOSPITAL

Medical Imaging

Lead by Ivan Horak, PhD CEO
IMMUNOMEDICS

Full speakers list for these workshops will be available soon.

Advisory Board Members:
Larry Blankstein, PhD Senior Director of Clinical Development ,Oncology
GENZYME

Steven Hamburger, Senior Director and Global Regulatory Strategic Leader Oncology Department
JOHNSON & JOHNSON PHARMACEUTICAL R&D

Ivan Horak, MD, Executive Vice President, Research and Development
IMMUNOMEDICS

Gary Schwartz, PHD
MEMORIAL SLOAN KETTERING CANCER CENTER

Fabio Benedetti , PhD, VP of Global Medical Affairs
MILLENNIUM PHARMACEUTICALS

Elise Kohn, PhD
NATIONAL CANCER INSTITUTE

Michael Schuster, MD, Director of Clinical Trials Division of Hematology/Oncology
NEW YORK PRESBYTERIAN HOSPITAL

William Gradishar Associate Professor of Medicine Division of Hematology and Medical Oncology
NORTHWESTERN UNIVERSITY

Lee Allen, PhD, Director of Oncology
WYETH

Venue

Types